Issue |
Title |
File |
Vol 26, No 4 (2024) |
Immunological predictors of the therapeutic efficacy of atezolizumab in combination with nab-paclitaxel in metastatic triple-negative breast cancer: A pilot multicenter retrospective associative study |
 (Rus)
|
Kalinchuk A.Y., Popova N.O., Gofman A.A., Usoltseva I.S., Perelmuter V.M., Tashireva L.A.
|
Vol 8, No 1 (2006) |
Immuno-morfologicheskie faktory prognoza pri limfome Khodzhkina |
|
Tumyan G.S., Tupitsyn N.N., Probatova N.A., Kovrigina A.M., Sholokhova E.N.
|
Vol 24, No 1 (2022) |
Immuno-morphological characteristics of bone marrow in patients with ovarian cancer |
 (Rus)
|
Kozhonalieva A.M., Chulkova S.V., Stilidi I.S., Artamonova E.V., Poddubnaya I.V., Kolbatskaya O.P., Kupryshina N.A., Egorova A.V., Tupitsyn N.N.
|
Vol 14, No 4 (2012) |
Immunoterapiya dendritnymi kletkami v klinicheskoy onkologii* |
|
Shevtsov M.A., Khachatryan V.A., Galibin O.V., Margulis B.A.
|
Vol 21, No 3 (2019) |
Immunotherapy in combination with chemotherapy in triple-negative breast cancer - the first “target” therapy for the “target” patients’ population |
 (Rus)
|
Grechukhina K.S., Zhukova L.G.
|
Vol 18, No 2 (2016) |
Improved technique thyroidectomy with lateral modified radical neck dissection |
 (Rus)
|
Shabunin A.V., Dolidze D.D., Podvyaznikov S.O., Melnik K.V., Mumladze R.B., Vardanyan A.V., Lebedinskiy I.N., Grachev P.V.
|
Vol 22, No 4 (2020) |
Improving early breast cancer treatment: the role of granulocyte colony-stimulating factor |
 (Rus)
|
Ganshina I.P., Ivanova K.A., Lubennikova E.V., Arkhipov A.V., Zhukova L.G.
|
Vol 25, No 1 (2023) |
Improving outcomes for people with a primary malignant brain tumour and their carers through early palliative interventions |
 (Rus)
|
Ivanchenko K.A.
|
Vol 26, No 3 (2024) |
Increasing the effectiveness of total-skin electron beam therapy by reducing the manifestations of radiation dermatitis in patients with primary lymphomas. A comparative randomized prospective study |
 (Rus)
|
Zelianina M.I., Vinogradova Y.N., Zaslavskiy D.V., Gilvanova E.V., Ilyin N.V.
|
Vol 5, No 3 (2003) |
Infektsii zheludochno - kishechnogo trakta u onkologicheskikh bol'nykh: sovremennye podkhody k lecheniyu |
|
Shevola D., Dmitrieva N.V., Petukhova I.N., Varlan G.V., Averina N.A., Volkova Z.V., Petrukhina N.N., Korotkov A.M.
|
Vol 23, No 3 (2021) |
Influence of correction of nutritive deficiency on the effectiveness of neoadjuvant chemotherapy in patients with locally advanced gastric cancer |
 (Rus)
|
Brish N.A., Semiglazova T.Y., Karachun A.M., Shevkunov L.N., Ulyanchenko Y.A., Artemyeva A.S., Golovanova T.S., Tkachenko E.V., Alexeeva Y.V., Sharashenidze S.M., Strakh L.V., Protsenko S.A., Teletaeva G.M., Filatova L.V., Kasparov B.S., Semiglazov V.V., Belyaev A.M.
|
Vol 25, No 1 (2023) |
Influence of radiation therapy on the development of complications in single-stage autologous breast reconstruction with a DIEP-flap in breast cancer patients: a retrospective study |
 (Rus)
|
Duadze I.S., Kaprin A.D., Zikiryakhodzhaev A.D., Reshetov I.V., Usov F.N., Rasskazova E.A., Sukhotko A.S., Starkova M.V., Bagdasarova D.V., Dzhabrailova D.S., Khakimova S.G.
|
Vol 23, No 4 (2021) |
Influence of retroelements on oncogenes and tumor suppressors in carcinogenesis: A review |
 (Rus)
|
Mustafin R.N.
|
Vol 12, No 4 (2010) |
Informatsionnoe soobshchenie o XXIVsemirnom protivorakovom kongresse |
|
Kachanov D.Y.
|
Vol 6, No 3 (2004) |
Informatsiya o nachale provedeniya mezhdunarodnogo issledovaniya metoda lecheniya bol'nykh s follikulyarnoy nekhodzhkinskoy CD20+ V-kletochnoy limfomoy |
|
- -.
|
Vol 5, No 2 (2003) |
Ingibin A, estradiol, FSG i SA-125 v diagnostike i monitoringe granulezokletochnoy opukholi yaichnikov |
|
Kerzhkovskaya N.S., Lyubimova N.V., Zhordania K.I., Bogatyrev V.N., Rotobel'skaya L.E., Anurova O.A., Barinov V.V.
|
Vol 3, No 2 (2001) |
Ingibitor signal'nykh putey STI 571 (Signal Transductor Inhibitor) - novoe napravlenie v lechenii khronicheskogo mieloleykoza |
|
Turkina A.G.
|
Vol 12, No 4 (2010) |
Ingibitory angiogeneza v terapiiepitelial'nogo raka yaichnikov |
|
Tyulyandin S.A., Tyulyandina A.S.
|
Vol 14, No 4 (2012) |
Ingibitory tirozinkinazy EGFR v terapii 1-y linii nemelkokletochnogo raka legkogo: perekhod ot empiricheskogo podkhoda k personalizatsii lecheniya |
|
Artamonova E.V.
|
Vol 12, No 3 (2010) |
Ingibitory tirozinkinazy retseptoraepidermal'nogo faktora rosta:pokhozhie, no raznye? (Referat) |
|
Bychkov M.B., Bol'shakova S.A., Bychkov Y.M.
|
Vol 9, No 3 (2007) |
Ingibitory vnutrikletochnoy peredachi signala pri melanome: perspektivy i razocharovaniya targetnoy terapii |
|
Konstantinova M.M.
|
Vol 22, No 2 (2020) |
Inhibin B in diagnosis and monitoring of granulosa-cell tumors of ovary |
 (Rus)
|
Lyubimova N.V., Beishembaev A.M., Timofeev Y.S., Zhordania K.I., Kushlinskii N.E.
|
Vol 25, No 3 (2023) |
Initial treatment for adults with advanced kidney cancer (renal cell carcinoma) [Russian translation of the Plain Language Summary (PLS) of the Cochrane Systematic Review] |
 (Rus)
|
Melnikov V.D.
|
Vol 23, No 4 (2021) |
Innovations in practice. 5 years of palbociclib experience in the Russian Federation. Overview of web-conference took place on 8 October 2021 |
 (Rus)
|
Editorial B.
|
Vol 24, No 2 (2022) |
Innovations in the therapy of oncohematological diseases |
 (Rus)
|
Editorial B.
|
Vol 18, No 1 (2016) |
Insulin-like growth factors in patients with ovarian tumors (results of own research) |
 (Rus)
|
Knyazev R.I., Kuznetsov V.V., Bokin I.I., Barinov V.V., Kushlinskiy N.E., Poddubnaya I.V.
|
Vol 26, No 1 (2024) |
Intensity of repeated disability due to brain malignancies in the female population in Moscow for 2017–2021 |
 (Rus)
|
Zaparii S.P., Potapenko O.I.
|
Vol 19, No 2 (2017) |
Interferon α (IFN-α) vs. the combination IFN-α and octreotide LAR in the treatment of patients with well differentiated neuroendocrine tumors (NET) of various localizations |
 (Rus)
|
Yemelyanova G.S., Kuzminov A.E., Orel N.F., Markovich A.A., Kuznetsova A.A., Gorbunova V.A.
|
Vol 26, No 4 (2024) |
Interim results analysis of the PERFECTION observational study in patients with metastatic non-small cell lung cancer |
 (Eng)
|
Laktionov K.K., Fedyanin M., Stroyakovskiy D.L., Mochalova A.S., Iasieva A.R., Fadeeva N.V., Shapovalova I.S., Mironov O.V., Dergunov A.S., Orlov S.V., Vasilev L.A., Bobrova E.A., Orlova S.A., Kosukhina A.A., Polshina N.I., Vardanian S.G., Fedoseev A.I., Tumasian K.S., Danilova A.E., Krashikhina T.V., Tsygankova E.I., Staritsyn D.E., Toporkova O.V., Boskhomdzhieva M.V., Sultanbaev A.V., Edamenko M.V., Dmitriev V.N., Shkradiuk A.V., Shkret K.A., Prosianikova O.N., Svechnikov E.V., Grigorchuk S.Y.
|
Vol 22, No 4 (2020) |
Interim results of a multicenter retrospective-prospective observational post-marketing study of Extimia® BIOCAD (INN: empegfilgrastim) to evaluate safety and efficacy in patients with lymphoproliferative diseases receiving cytotoxic therapy |
 (Rus)
|
Nesterova E.S., Klitochenko T.Y., Glonina N.N., Fadeeva N.V., Sannikova T.A., Lyalina I.S., Shelekhova T.V., Sherstnev D.G., Voloshin S.V., Sarzhevskii V.O., Hofman A.A., Ichshanov D.G., Poddubnaya I.V.
|
Vol 27, No 2 (2025) |
Interim results of an multicenter observational clinical study on treatment strategies for chronic lymphocytic leukemia/small lymphocytic lymphoma in Russia |
 (Rus)
|
Poddubnaya I.V., Ptushkin V.V.
|
Vol 26, No 3 (2024) |
Intermediate results of efficacy and safety of combined treatment with brentuximab vedotin and bendamustine for refractory and relapsed forms of peripheral T-cell lymphoma: A retrospective study |
 (Rus)
|
Pozharskii E.D., Chernova N.G., Dareeva Y.G., Nikitin E.A., Zakharov O.D., Misyurina E.N., Dudina G.A., Semina T.A., Ptushkin V.V.
|
Vol 27, No 2 (2025) |
Intermediate results of the PERFECTION observational study in a population of patients with metastatic, persistent and recurrent cervical cancer |
 (Rus)
|
Saevets V.V., Kuzmin N.K., Ponomareva N.A., Krashikhina T.V., Mochalova A.S., Vasilyev L.A., Stroyakovsky D.L., Kolomiets L.A., Averyanova S.V., Yavorskaya M.A., Orlova S.A., Boskhomjieva M.V., Peganova E.V., Shalina A.I., Kosukhina A.A., Khaikin A.M., Shkradyuk A.V., Bobrova E.A., Dikhtyar T.N., Shikina V.E., Sultanbaev A.V., Kudryavtsev I.Y., Zinkina-Orikhan A.V., Fogt S.N., Kiseleva P.V., Svechnikov E.V.
|
Vol 19, No 2 (2017) |
Internal mammary nodes metastases for breast cancer: whether the morphological verification is necessary? |
 (Rus)
|
Trigolosov A.V., Uimanov V.A., Chernikh M.V., Petrovskiy A.V., Nikitina E.A., Nechushkin M.I.
|
Vol 25, No 3 (2023) |
International experience by using of the SJMB protocols in treatment of children with medulloblastoma in the age group over 3 years (literature review) |
 (Rus)
|
Levashov A.S., Zagidullina S.R., Valiev T.T., Stroganova A.M., Khochenkov D.A., Grigorenko V.A., Mikhaylova E.V., Tyurina E.V., Ryzhova M.V., Horielyshev S.K., Kadyrov S.U., Polyakov V.G.
|
Vol 14, No 3 (2012) |
Internet-konferentsiya «Follikulyarnye limfomy» |
|
- -.
|
Vol 25, No 2 (2023) |
Interrelation of HLA-I and class II major histocompatibility complex molecules with clinical and morphological signs of breast cancer: A retrospective cohort study |
 (Rus)
|
Chulkova S.V., Sholokhova E.N., Poddubnaya I.V., Stilidi I.S., Burov D.A., Tupitsyn N.N.
|
Vol 17, No 2 (2015) |
Intrahepatic cholangiocellular carcinoma (review) |
|
Zharikov Y.O., Shevchenko T.V., Zhao A.V.
|
Vol 3, No 2 (2001) |
Invazivnye mikozy v onkogematologii: sovremennoe sostoyanie problemy |
|
Klyasova G.A.
|
Vol 19, No 3 (2017) |
Irreversible electroporation of locally advanced unresectable pancreatic cancer |
 (Rus)
|
Patyutko Y.I., Polyakov A.N., Kudashkin N.E., Podluzhnyi D.V., Chistyakova O.V.
|
Vol 26, No 2 (2024) |
Is maintenance therapy following previous treatment better than observation or placebo for treating chronic lymphocytic leukaemia in adults? (Russian translation of the Plain Language Summary (PLS) of the Cochrane Systematic Review) |
 (Rus)
|
Editorial B.
|
Vol 23, No 2 (2021) |
Isatuximab, a novel anti-CD38 monoclonal antibody in the treatment of multiple myeloma: efficacy and safety |
 (Rus)
|
Zatolochina K.E., Zyryanov S.K., Ushkalova E.A.
|
Vol 26, No 4 (2024) |
Isatuximab-containing regimens for the treatment of patients with newly diagnosed multiple myeloma: A literature review and a clinical case |
 (Rus)
|
Soloveva M.V., Solovev M.V., Kovrigina A.M., Mendeleeva L.P.
|
Vol 26, No 1 (2024) |
Isolated metastasis to the scalp in occult breast cancer: a clinical case |
 (Rus)
|
Ognerubov N.A., Sergeev R.S., Hizhnyak A.O., Ognerubova M.A., Dzhabrailov M.A.
|
Vol 27, No 1 (2025) |
Isolated metastatic lesion of hyoid bone in gastric cancer: A rare case |
 (Rus)
|
Ognerubov N.A., Antipova T.S.
|
Vol 23, No 1 (2021) |
Isolated splenic metastases from colon cancer: clinical observations |
 (Rus)
|
Ognerubov N.A., Antipova T.S., Ognerubova M.A.
|
Vol 10, No 3 (2008) |
Ispol'zovanie generikov v onkologii: est' li problemy? |
|
Zyryanov S.K., Belousov Y.B.
|
Vol 9, No 2 (2007) |
Ispol'zovanie komp'yuternoy obrabotki dannykh videoendoskopicheskogo issledovaniya gortani v planirovanii i otsenke rezul'tatov lecheniya raka gortani |
|
Shinkarev S.A., Korenev A.A., Podol'skiy V.N., Bobrovskiy A.V., Shinkareva E.V.
|
Vol 4, No 4 (2002) |
Ispol'zovanie metoda AKS dlya kolichestvennoy otsenki "otveta na lechenie" onkologicheskikh bol'nykh |
|
Teplyakov V.V., Lebedenko I.M., Kovalevskiy E.E.
|
Vol 14, No 3 (2012) |
Ispol'zovanie pokazatelya effektivnosti zatrat pri kompleksnoy farmakoekonomicheskoy otsenke dorogostoyashchikh meditsinskikh tekhnologiy. Primer bevatsizumaba |
|
Ryazhenov V.V., Gorokhova S.G.
|
Vol 4, No 3 (2002) |
Ispol'zovanie rekonstruktivnykh plasticheskikh operatsiy v lechenii opukholey golovy i shei |
|
Azizyan R.I., Podvyaznikov S.O., Fedotenko S.P., Taneeva A.S., Matakova I.S.
|
Vol 9, No 2 (2007) |
Issledovanie III fazy pokazalo, chto primenenie Neksavara® na 44% uvelichivaet obshchuyu vyzhivaemost' u bol'nykh rakom pecheni 4 iyunya 2007 g., Berlin |
|
- -.
|
Vol 14, No 2 (2012) |
Issledovanie III fazy: znachitel'noe uvelichenie prodolzhitel'nosti zhizni u patsientov s naibolee rasprostranennym tipom nemelkokletochnogo raka legkogo, poluchavshikh prodolzhennuyu podderzhivayushchuyu terapiyu na osnove preparata Alimta |
|
- -.
|
Vol 3, No 1 (2001) |
Issledovanie vozmozhnykh mekhanizmov regulyatsii rosta razlichnykh novoobrazovaniy u detey |
|
Dumbrays K.O., Kushlinskiy N.E., Gershteyn E.S., Glazkova T.G., Baykova V.N., Durnov L.A.
|
Vol 10, No 4 (2008) |
Itogovyy press-reliz |
|
- -.
|
Vol 5, No 2 (2003) |
Izmenenie kislorodzavisimoy antikandidoznoy i antimikrobnoy aktivnosti neytrofilov onkogematologicheskikh bol'nykh so smeshannoy gribkovo-bakterial'noy infektsiey pri terapii s ispol'zovaniem rchG-KSF |
|
Nikiforova Z.N., Shevchenko V.E., Dmitrieva N.V., Arnotskaya N.E., Stan'chik T.
|
Vol 13, No 1 (2011) |
Izmenenie podkhoda k lecheniyu platinochuvstvitel'nykh retsidivov raka yaichnikov |
|
Khokhlova S.V., Gorbunova V.A.
|
Vol 3, No 1 (2001) |
Izuchenie effektivnosti i bezopasnosti tomudeksa * v 1 - y linii terapii u bol'nykh rasprostranennym kolorektal'nym rakom |
|
Lichinitser M.R., Dobrova N.V., Garin A.M., Bazin I.S., Gorbunova V.A., Voznyy E.K., Dobrovol'skaya N.Y., Kononenko I.B., Odintsov S.V.
|
Vol 12, No 3 (2010) |
Izuchenie gemtsitabina (Gemzar®)i tsisplatina v pervoy linii terapiirasprostranennogo raka yaichnika(issledovanie II fazy) |
|
Gorbunova V.A., Kovalenko N.V., Shevyakova E.V., Gotovkin E.A., Lisyanskaya A.S., Dvornichenko V.V., Byakhov M.Y., Petukhova I.N.
|
Vol 14, No 1 (2012) |
K 80-letiyu so dnya rozhdeniya akademika RAMNL'va Abramovicha Durnova (1931-2005) |
|
- -.
|
Vol 8, No 2 (2006) |
K voprosu o diagnostike raka yaichnikov pri polineoplaziyakh |
|
Payanidi Y.G., Sel'chuk V.Y., Zhordania K.I., Asanov A.Y., Zakharova T.I., Savelov N.I.
|
Vol 14, No 2 (2012) |
K voprosu o real'nykh vozmozhnostyakh luchevoy terapii mestnorasprostranennykh rakov kozhi chelyustno-litsevoy oblasti |
|
Garbuzov M.I.
|
Vol 11, No 2 (2009) |
Kachestvo zhizni i simptomyu bol'nykh disseminirovannym gormonopozitivnym rakom molochnoy zhelezy v postmenopauze na fone primeneniya Fazlodeksa |
|
Novik A.A., Ionova T.I., Kalyadina S.A.
|
Vol 12, No 3 (2010) |
Kapetsitabin v ad\"yuvantnoy terapiiraka molochnoy zhelezy |
|
Kolyadina I.V., Poddubnaya I.V.
|
Vol 13, No 3 (2011) |
Kapetsitabin v terapiiantratsiklin- i taksanrezistentnogoraka molochnoy zhelezy |
|
Kovalenko E.I., Artamonova E.V., Satirova E.F., Manzyuk L.V.
|
Vol 6, No 3 (2004) |
Kardiotoksichnost' antratsiklinov: vozmozhnosti preodoleniya |
|
Orel N.F.
|
Vol 13, No 4 (2011) |
Kartsinoma Merkelya |
|
Orlova K.V., Orel N.F., Markovich A.A., Demidov L.V.
|
Vol 3, No 3 (2001) |
Kateter-assotsiirovannye infektsii |
|
Sidorenko S.V.
|
Vol 8, No 1 (2006) |
Keliks (pegilirovannyy liposomal'nyy doksorubitsin) v programmnoy terapii 2-y linii metastaticheskogo raka molochnoy zhelezy |
|
- -.
|
Vol 16, No 4 (2014) |
Keratoacanthoma: possible management approaches. Case reports |
|
Teterin K.A., Kizhaev Y.E., Bolotova N.P.
|
Vol 9, No 4 (2007) |
Kharakteristika granulotsitarnogo koloniestimuliruyushchego faktora: pokazaniya k primeneniyu |
|
Finogenova N.A.
|
Vol 2, No 1 (2000) |
Khimioimmunoterapiya disseminirovannoy melanomy |
|
Bulat Y.V.
|
Vol 14, No 3 (2012) |
Khimioluchevaya terapiya ploskokletochnogo mestnorasprostranennogo anal'nogo raka (klinicheskiy sluchay) |
|
Elizbaryan K.S., Kazantseva M.V., Davidenko I.S., Potemin S.N., Andreev D.V., Burdik O.P., Stukan' A.I.
|
Vol 12, No 2 (2010) |
Khimioterapiya bol'nykhrasprostranennym rakom tolstoy kishki |
|
Fedyanin M.Y., Tryakin A.A., Tyulyandin S.A.
|
Vol 6, No 2 (2004) |
Khimioterapiya nemelkokletochnogo raka legkogo s ispol'zovaniem oksaliplatina(eloksatin) |
|
Bychkov M.B., Bol'shakova S.A., Bychkov Y.M.
|
Vol 6, No 2 (2004) |
Khimioterapiya nemelkokletochnogo raka legkogo: vybor pervoy linii |
|
Gorbunova V.A.
|
Vol 12, No 2 (2010) |
Khimioterapiya raka sheyki matki:rol' topotekana v bor'be za uvelichenievyzhivaemosti i uluchshenie kachestvazhizni patsientov |
|
Kharitonova T.V., Poddubnaya I.V.
|
Vol 4, No 1 (2002) |
Khimioterapiya v lechenii zlokachestvennykh vnutrimozgovykh opukholey |
|
Kobyakov G.L.
|
Vol 14, No 2 (2012) |
Khirurgicheskoe lechenie mestnorasprostranennogo i retsidivnogo orofaringeal'nogo raka v plane kombinirovannogo i kompleksnogo podkhoda |
|
Sikorskiy D.V., Volodin A.N., Chernyavskiy A.A., Podvyaznikov S.O.
|
Vol 14, No 4 (2012) |
Khirurgiya raka zheludka u bol'nykh starcheskogo vozrasta: sovremennoe sostoyanie problemy |
|
Stilidi I.S., Nered S.N., Rokhoev G.A.
|
Vol 8, No 4 (2006) |
Khronicheskiy B-kletochnyy limfoleykoz: faktory prognoza pri lechenii fludarabinom i khlorambutsilom |
|
Nikitin E.A.
|
Vol 8, No 2 (2006) |
Khronicheskiy virusnyy gepatit S i limfoproliferativnye zabolevaniya |
|
Lepkov V., Storozhakov G.I., Kosyura S.D., Volynkina V.M., Oskanova R.S., Sherstnev V.M., Kondrat'eva T.T., Sholokhova E.N., Probatova N.A.
|
Vol 3, No 3 (2001) |
Kislorodzavisimaya antikandidoznaya aktivnost' neytrofilov onkologicheskikh bol'nykh posle terapii G-KSF |
|
Nikiforova Z.N., Shevchenko V.E., Dmitrieva N.V., Arnotskaya N.E.
|
Vol 11, No 3 (2009) |
Klinicheskaya effektivnost'i bezopasnost' primeneniya otechestvennogo rekombinantnogo granulotsitarnogo koloniestimuliruyushchego faktora Neypomaks® u bol'nykh rakom molochnoy zhelezy, poluchayushchikh khimioterapiyu doksorubitsinom i dotsetakselom |
|
Zhukova L.G., Abramov M.E., Vakhabova Y.V., Lud A.N., Obukhov A.A., Lichinitser M.R.
|
Vol 10, No 3 (2008) |
Klinicheskie aspekty limfadenopatiy |
|
Melikyan A.L.
|
Vol 13, No 2 (2011) |
Klinicheskie rekomendatsii po profilaktikei lecheniyu toshnoty i rvoty u bol'nykh,poluchayushchikh khimio- i luchevuyuprotivoopukholevuyu terapiyu |
|
Poddubnaya I.V., Lichinitser M.R., Tyulyandin S.A., Gorbunova V.A., Ptushkin V.V., Abramov M.A., Besova N.S., Bolotina L.V., Bulavina I.S., Gladkov O.A., Davidenko I.S., Zhukova L.G., Koroleva I.A., Korolenko V.O., Manikhas G.M., Snegovoy A.V., Tyukalov Y.I., Khasanov R.S., Shigapova L.N.
|
Vol 18, No 1 (2016) |
Klinicheskie sluchai lecheniya gepatotsellyulyarnogo raka v Rossii. Klinicheskiy sluchay 1 Bolee chem 3-letnyaya stabilizatsiya protsessa gepatotsellyulyarnogo raka na fone dlitel'nogo priema preparata sorafenib |
 (Rus)
|
Sheko S.S., Dem'yanova G.A.
|
Vol 18, No 1 (2016) |
Klinicheskie sluchai lecheniya gepatotsellyulyarnogo raka v Rossii.Klinicheskiy sluchay 2 Opyt lecheniya patsienta s gepatotsellyulyarnoy kartsinomoy posle transplantatsii pecheni |
 (Rus)
|
Davydenko M.N., Petrovskiy A.N.
|
Vol 3, No 3 (2001) |
Klinicheskie vozmozhnosti ispol'zovaniya tomudeksa v terapii kolorektal'nogo raka |
|
Voznyy E.K., Dobrovol'skaya N.Y., Kononenko I.B.
|
Vol 1, No 2 (1999) |
Klinicheskiy opyt ispol'zovaniya antiemetika kitrila v onkologii |
|
Borisov V.I.
|
Vol 8, No 1 (2006) |
Klinicheskiy opyt primeneniya zomety u bol'nykh mnozhestvennoy mielomoy (rezul'taty Rossiyskogo mnogotsentrovogo issledovaniya) |
|
Votyakova O.M., Khoroshko N.D., Zhuravlev V.S., Shamray V.S., Korobkin V.A., Shelekhova N.M.
|
Vol 15, No 3 (2013) |
Klinicheskiy primer uspeshnogo lecheniya limfedemy u bol'noy s postmastektomicheskim sindromom |
|
Makarova V.S.
|
Vol 11, No 3 (2009) |
Klinicheskiy sluchay effektivnogo lecheniya lapatinibom (Tayverb)i kapetsitabinom (Kseloda) bol'noy disseminirovannym rakom molochnoy zhelezy s giperekspressiey ErbB2 (Her-2/neu) s metastaticheskim porazheniem veshchestva i obolochek golovnogo mozga |
|
Naskhletashvili D.R., Chmutin G.E.
|
Vol 13, No 3 (2011) |
Klinicheskiy sluchay primeneniyalapatiniba v kombinatsiis kapetsitabinom u patsientkis tserebral'nym metastazomHER-2-pozitivnogo raka molochnoyzhelezy |
|
Davydenkov A.V., Ovchinnikova Y.S.
|
Vol 4, No 3 (2002) |
Klinicheskoe izuchenie rezhima tomudeks + 5-ftoruratsil pri metastazakh kolorektal'nogo raka |
|
Semenov N.N., Lichinitser M.R.
|
Vol 3, No 1 (2001) |
Klinicheskoe techenie bolezni Khodzhkina u detey pubertatnogo vozrasta |
|
Gordina G.A., Kiselev A.V., Makhonova L.A., Il'yashenko V.V., Susuleva N.A., Slugin A.I.
|
Vol 2, No 4 (2000) |
Klinicheskoe znachenie protivoopukholevogo preparata «Myustoforan» |
|
Poddubnaya I.V.
|
Vol 6, No 2 (2004) |
Klinicheskoe znachenie sistemy aktivatsii plazminogena u bol'nykh rakom zheludka |
|
Kaz'min A.I., Ognerubov N.A., Gershteyn E.S., Kushlinskiy N.E.
|
Vol 14, No 2 (2012) |
Kliniko-ekonomicheskiy analiz primeneniya everolimusa (Afinitor) pri metastaticheskom rake pochki s uchetom kolichestva dobavlennykh let zhizni s popravkoy na kachestvo zhizni |
|
Kolbin A.S., Kurylev A.A., Proskurin M.A., Balykina Y.E.
|
Vol 6, No 2 (2004) |
Kliniko-geneticheskaya geterogennost' semeynogo raka molochnoy zhelezy |
|
Lyubchenko L.N., Gar'kavtseva R.F.
|
401 - 500 of 1398 Items |
<< < 1 2 3 4 5 6 7 8 9 10 11 12 13 14 > >> |